Mehta Shanti, Xiong Grace, Metko Dea, Abdi Parsa, McMullen Eric, Alhusayen Raed
Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
JAMA Dermatol. 2025 Jul 16. doi: 10.1001/jamadermatol.2025.2281.
Psoriasis affects up to 3% of the population, with 30% of patients with psoriasis developing psoriatic arthritis (PsA), yet the transition between psoriasis and PsA has yet to be fully understood. Subclinical synovitis is a hallmark of PsA and is thought to precede psoriatic arthritis; its detection among patients with psoriasis without musculoskeletal (MSK) involvement through medical imaging modalities could offer valuable insights into the transition from psoriasis to PsA.
To evaluate the prevalence of synovitis on ultrasonograms and magnetic resonance imaging (MRI) among patients with psoriasis without MSK involvement compared with healthy controls and patients with PsA.
A comprehensive literature search was conducted in MEDLINE, Embase, Scopus, and Web of Science from inception to October 2024 using keywords related to psoriasis, synovitis, and medical imaging. A PROSPERO protocol was registered (CRD42024571308).
Studies were eligible if they included patients with psoriasis without MSK involvement and assessed synovitis using imaging. Two reviewers independently screened studies and extracted data. Discrepancies were resolved by consensus. Twelve of 5132 initially identified studies met inclusion criteria.
Data were extracted per PRISMA guidelines. Risk of bias was assessed using the Newcastle-Ottawa Scale. A random-effects model was used to pool risk ratios (RRs) for synovitis prevalence across comparison groups. Heterogeneity was assessed using the I2 statistic.
The primary outcome was the presence of imaging-detected synovitis among patients with psoriasis without MSK involvement compared with healthy controls and patients with PsA.
Twelve studies (N = 2606 patients) were included comprising 1593 patients with psoriasis (mean [SD] age, 46.4 [7.5] years; 982 men [61.6%]), 327 patients with PsA (mean [SD] age, 50.2 [7.1] years; 210 men [64.2%]), and 686 healthy controls (mean [SD] age, 45.7 [6.9] years; 281 of 576 men [48.8%]). Synovitis was 2.5 times more likely among patients with psoriasis than controls (RR, 2.55; 95% CI, 1.18-5.52). Detection rates were higher with MRI (RR, 6.40; 95% CI, 1.87-21.95) than ultrasonography (RR, 2.50; 95% CI, 1.10-5.67). Synovitis was more frequent among patients with PsA than those with psoriasis, but the difference was not statistically significant (RR, 0.50; 95% CI, 0.13-1.87).
This systematic review and meta-analysis found that subclinical synovitis is significantly more prevalent among patients with psoriasis without MSK involvement compared with healthy controls. This finding suggests that imaging may aid in identifying individuals at risk for progression to psoriatic arthritis.
银屑病影响着高达3%的人口,其中30%的银屑病患者会发展为银屑病关节炎(PsA),然而银屑病与PsA之间的转变尚未完全明确。亚临床滑膜炎是PsA的一个标志,被认为先于银屑病关节炎出现;通过医学成像方式在无肌肉骨骼(MSK)受累的银屑病患者中检测到它,可能为银屑病向PsA的转变提供有价值的见解。
评估与健康对照和PsA患者相比,无MSK受累的银屑病患者超声检查和磁共振成像(MRI)上滑膜炎的患病率。
从数据库建立到2024年10月,在MEDLINE、Embase、Scopus和Web of Science中使用与银屑病、滑膜炎和医学成像相关的关键词进行了全面的文献检索。注册了一项PROSPERO方案(CRD42024571308)。
如果研究纳入了无MSK受累的银屑病患者并使用成像评估滑膜炎,则该研究符合条件。两名评审员独立筛选研究并提取数据。分歧通过协商解决。最初识别的5132项研究中有12项符合纳入标准。
按照PRISMA指南提取数据。使用纽卡斯尔-渥太华量表评估偏倚风险。使用随机效应模型汇总各比较组滑膜炎患病率的风险比(RR)。使用I²统计量评估异质性。
主要结局是与健康对照和PsA患者相比,无MSK受累的银屑病患者中通过成像检测到的滑膜炎的存在情况。
纳入了12项研究(N = 2606例患者),包括1593例银屑病患者(平均[标准差]年龄,46.4[7.5]岁;9个82名男性[61.6%])、327例PsA患者(平均[标准差]年龄,50.2[7.1]岁;210名男性[64.2%])和686名健康对照(平均[标准差]年龄,45.7[6.9]岁;576名男性中的281名[48.8%])。银屑病患者发生滑膜炎的可能性是对照组的2.5倍(RR,2.55;95%CI,1.18 - 5.52)。MRI的检出率(RR,6.40;95%CI,1.87 - 21.95)高于超声检查(RR,2.50;95%CI,1.10 - 5.67)。PsA患者的滑膜炎比银屑病患者更常见,但差异无统计学意义(RR,0.50;95%CI,0.13 - 1.87)。
这项系统评价和荟萃分析发现,与健康对照相比,无MSK受累的银屑病患者中亚临床滑膜炎的患病率显著更高。这一发现表明成像可能有助于识别有进展为银屑病关节炎风险的个体。